References
- European Monitoring Centre for Drugs and Drug Addiction. New drugs in Europe, 2012. EMCDDA-Europol 2012. Annual report on the implementation of Council Decision 2005/387/JHA; 2012.
- European Monitoring Centre for Drugs and Drug Addiction. New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015). Luxembourg: Publications Office of the European Union; 2015.
- US Drug Enforcement Administration, office of Diversion Control. National Forensic Laboratory Information System Special Report: Emerging 2C-phenethylamines, piperazines, and tryptamines in NFLIS, 2006–2011. Springfield, VA: US Drug Enforcement Administration; 2012.
- US Drug Enforcement Administration, Office of Diversion C. National Forensic Laboratory Information System: midyear report 2014. Springfield, VA: US Drug Enforcement Administration; 2015.
- US Drug Enforcement Administration, Office of Diversion Control. National Forensic Laboratory Information System Special Report: synthetic cannabinoids and synthetic cathinones reported in NFLIS, 2010–2013. Springfield, VA: US Drug Enforcement Administration; 2014.
- Law R, Schier J, Martin C, Chang A, Wolkin A. Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use – United States, January–May 2015. Morb Mortal Wkly Rep 2015;64:618–619.
- Substance Abuse and Mental Health Services Administration. Emergency department visits linked to “synthetic marijuana” products rising. October 16, 2014.
- American Association of Poison Control Centers. Synthetic marijuana data. August 11, 2015.
- American Association of Poison Control Centers. Bath salts data. July 31, 2015.
- Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC. 2011 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th annual report. Clin Toxicol 2012; 50:911–1164.
- Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M. 2012 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th annual report. Clin Toxicol 2013; 51:949–1229.
- Mowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M. 2013 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clin Toxicol 2014; 52:1032–283.
- US Drug Enforcement Administration. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. 21 CFR Part 1308. Fed Regist 2014;79:7577–7282.
- Wiley JL, Marusich JA, Huffman JW. Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. Life Sci 2013;23:531–534.
- Schifano F, Orsolini L, Duccio Papanti G, Corkery JM. Novel psychoactive substances of interest for psychiatry. World Psychiatry 2015;14:15–26.
- Palamar JJ, Acosta P. Synthetic cannabinoid use in a nationally representative sample of US high school seniors. Drug Alcohol Depend 2015;149:194–202.
- Miech RA, Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975–2014: Vol. I, Secondary school students. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2015.
- Palamar JJ. “Bath salt” use among a nationally representative sample of high school seniors in the United States. Am J Addict 2015;24:488–491.
- Miotto K, Striebel J, Cho AK, Wang C. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports. Drug Alcohol Depend 2013;132:1–12.
- Substance Abuse and Mental Health Services Administration. Report shows that “bath salts” drugs were involved in nearly 23,000 emergency department visits in one year. September 17, 2013.
- Orsolini L, Papanti GD, Francesconi G, Schifano F. Mind navigators of chemicals’ experimenters? A web-based description of e-psychonauts. Cyberpsychol Behav Soc Netw 2015;18:296–300.
- Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. 2010 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 28th annual report. Clin Toxicol 2011; 49:910–941.
- Forrester MB. 2C series phenethylamine derivative exposures in Texas. Subst Abuse 2013;34:81–82.
- Forrester MB. NBOMe designer drug exposures reported to Texas poison centers. J Addict Dis 2014;33:196–201.
- Helander A, Beck O, Hagerkvist R, Hulten P. Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project. Scand J Clin Lab Invest 2013;73:400–406.
- Murphy CM, Dulaney AR, Beuhler MC, Kacinko S. “Bath salts” and “plant food” products: the experience of one regional US poison center. J Med Tox 2013;9:42–48.
- Carhart-Harris RL, King LA, Nutt DJ. A web-based survey on mephedrone. Drug Alcohol Depend 2011;118:19–22.
- Elliott S, Evans J. A 3-year review of new psychoactive substances in casework. Forensic Sci Int 2014;243:55–60.
- Mohr ALA, Yeakel JK, Friscia M, Logan BK. Recreational drug use trends and emerging analytes identified in blood, urine, and/or oral fluid from attendees at an electronic dance music festival. Center for Forensic Science Research & Education. Presentation at Toxicology Section; 2015.
- Palamar JJ, Martins SS, Su MK, Ompad DC. Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug Alcohol Depend 2015; 156:112–119.
- Rogers S. Which drugs do you take? US and the UK compared by the Global Drug Survey. The Guardian; 2012.
- Palamar JJ, Griffin-Tomas M, Ompad DC. Illicit drug use among rave attendees in a nationally representative sample of US high school seniors. Drug Alcohol Depend 2015;152:24–31.
- Wu P, Liu X, Pham TH, Jin J, Fan B, Jin Z. Ecstasy use among US adolescents from 1999 to 2008. Drug Alcohol Depend 2010;112:33–38.
- Palamar JJ, Kamboukos D. An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States. Subst Use Misuse 2014;49:1774–1783.
- Caviness CM, Tzilos G, Anderson BJ, Stein MD. Synthetic cannabinoids: use and predictors in a community sample of young adults. Subst Abus 2014;36:368–373.
- Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus 2014;35:184–189.
- Winstock AR, Barratt MJ. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend 2013;131:106–111.
- Barratt MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev 2013;32:141–146.
- Ridpath A, Driver CR, Nolan ML, Karpati A, Kass D, Paone D, Jakubowski A, et al. Illnesses and deaths among persons attending an electronic dance-music festival – New York City, 2013. Morb Mortal Wkly Rep 2014;63:1195–1198.